Pituitary-adrenal axis response to arginine vasopressin in patients with major depression
- PMID: 8387217
- DOI: 10.1016/0165-1781(93)90014-8
Pituitary-adrenal axis response to arginine vasopressin in patients with major depression
Abstract
Arginine vasopressin (AVP) was administered to 21 patients with major depression and 20 normal control subjects. Thirty-two subjects also underwent an overnight dexamethasone suppression test. The patient group did not differ significantly from the control group in adrenocorticotropic hormone (ACTH) or cortisol response. Dexamethasone suppression status did not affect ACTH or cortisol response. This study supports the hypothesis that unlike the response to corticotropin releasing hormone, the ACTH response to AVP is not attenuated in depression.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
